Jeffrey Berkowitz's most recent trade in Esperion Therapeutics Inc. was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 26, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics Inc. | Jeffrey Berkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
Esperion Therapeutics Inc. | Jeffrey Berkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,376 | 23,449 (0%) | 0% | 0 | Common Stock | |
Esperion Therapeutics Inc. | Jeffrey Berkowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 6,106 | 11,073 (0%) | 0% | 0 | Common Stock |